XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Activities    
Net Income Including the Noncontrolling Interests in Subsidiaries $ 54,597 $ 74,346
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities    
Depreciation and Amortization 7,462 7,473
Share-Based Compensation Expense 9,288 9,216
Subsidiary Share-Based Compensation Expense 707 2,482
(Gain) Loss on Disposal of Assets (150) (1,684)
Provision (Benefit) for Deferred Income Taxes 2,342 3,597
Consolidation/(Deconsolidation) of Other Entities (20) 11,789
Net Unrealized (Gain) Loss on Investments 11,847 322
Net Sales (Purchases) of Investments—Consolidated Investment Companies (30,937) (51,127)
Other Changes in Assets and Liabilities:    
(Increase) Decrease in Receivables, net 9,843 6,742
(Increase) Decrease in Prepaid Expenses and Other Assets (2,892) (3,342)
Increase (Decrease) in Accounts Payable and Accrued Expenses (88,206) (101,616)
Increase (Decrease) in Other Liabilities 6,872 11,789
Net Cash Provided (Used) by Operating Activities (19,247) (30,013)
Investing Activities    
Purchases of Investments—Affiliates and Other (2,008) (1,811)
Proceeds from Redemptions of Investments—Affiliates and Other 1,321 2,466
Cash Paid for Property and Equipment (1,853) (2,159)
Net Cash Provided (Used) by Investing Activities (2,540) (1,504)
Financing Activities    
Dividends Paid (24,953) (26,788)
Purchases of Treasury Stock (113,338) (39,073)
Distributions to Noncontrolling Interests in Subsidiaries (4,339) (1,898)
Contributions from Noncontrolling Interests in Subsidiaries 30,340 25,762
Proceeds from New Borrowings 488,300 0
Payments on Debt (311,650) (5,000)
Other Financing Activities (9,499) (1,993)
Net Cash Provided (Used) by Financing Activities 54,861 (48,990)
Effect of Exchange Rates on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (4,505) 1,270
Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28,569 (79,237)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning of Period 238,052 308,635
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period 266,621 229,398
Less: Restricted Cash Recorded in Other Current Assets 4,289 6,507
Less: Restricted Cash and Restricted Cash Equivalents Recorded in Other Long-Term Assets 289 286
Cash and Cash Equivalents $ 262,043 $ 222,605